Mobile Site ›

The Use of Genetics in Guiding Therapy

Mayo Test for Warfarin Sensitivity

Slide 17

June 2012

Mayo Medical Laboratories offers a test that can be used as an aid for predicting an individual’s sensitivity to warfarin. This test is the Warfarin Sensitivity Genotype, which is a sequencing-based assay that detects the presence of CYP2C9 *2,*3, *5, and *6, the promoter variant in VKORC1, and any other rare variants that may occur in the regions sequenced. The CYP2C9 sequence genotype test may be additionally useful for psychiatry applications, as discussed later.

Mayo Test for Warfarin Sensitivity


Jump to section: